| Original language | English |
|---|---|
| State | Published - Apr 20 2005 |
Use of the substituted pyrimidine, KP544, as a potential pharmacotherapy for cognitive deficits in the Aron 63 transgenic mouse model of Huntington's disease
L York, Gary Dunbar
Research output: Other contribution